Fundraising Fox

Tempest Therapeutics

NASDAQ: TPST

Brisbane, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

SB
Stephen BradyDirector
CP
Christine PellizzariDirector
MA
Matthew AngelExecutive Officer, Director
RS
Ronit SimantovDirector
MR
Michael RaabDirector
NM
Nicholas MaestasExecutive Officer
TW
Thomas WoiwodeDirector
GN
Geoffrey NicholDirector
TW
Thomas W. DubenskyExecutive Officer, Director

Investors · 1

Reported raises · per SEC filings

Form D private placements
$4.1MraisedJun 2026 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • John David YeeDirector
  • Matthew AngelExecutive Officer, Director
  • Justin TrojanowskiExecutive Officer
  • William Drake RicheyDirector
Offering amount
$4.1M
Amount sold
$4.1M
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$2MraisedApr 2026 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen BradyDirector
  • Christine PellizzariDirector
  • Matthew AngelExecutive Officer, Director
  • Ronit SimantovDirector
  • Michael RaabDirector
  • Nicholas MaestasExecutive Officer
Offering amount
$2M
Amount sold
$2M
Sales commissions
$105K
First sale
Mar 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$15MraisedMay 2022 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Stephen R. BradyExecutive Officer, Director
  • Michael RaabDirector
  • Ronit SimantovDirector
  • Thomas WoiwodeDirector
  • Geoffrey NicholDirector
  • Thomas W. DubenskyExecutive Officer, Director
  • Christine PellizzariDirector
Offering amount
$15M
Amount sold
$15M
First sale
Apr 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news